Adolor Deploys Wireless Pharmaceutical Sales Software

Allentown, PA., March 22, 2005 - Target Software today announced that it has signed an agreement with Adolor Corporation (Nasdaq:ADLR) to implement the Target SFA sales effectiveness suite for Adolor's newly-formed surgeon-focused pharmaceutical field sales force.

Adolor representatives will manage their sales activities using Target Mobile running on Pocket PC phones operating Microsoft? Corporation's Windows Mobile? 2003 phone edition operating system and Verizon's new broadband mobile data access technology.

"Our sales representatives will have unprecedented access to information and convenient, secure communication tools in the field," comments Bob Strickler, Adolor's Director of Information Technology. "The system is designed to provide our reps with wireless internet access, email, instant messaging, and data synchronization capabilities. The goal is to maximize productivity, minimize administrative time, and facilitate collaborative efforts between each member of our sales team."

"Target SFA's unique .NET architecture makes our suite uniquely suited for the wireless environment," comments James Gardner, Target Software's Chief Operating Officer. "Wireless synchronization of Target Mobile means that sales representatives will be able to initiate all kinds of work processes from the field. We are working with several leading pharmaceutical industry suppliers to bring some very compelling real time service capabilities to fruition."

About Adolor Corporation

Adolor Corporation is a biopharmaceutical company specializing in the discovery, development and commercialization of prescription pain management products. Entereg? (alvimopan), Adolor's lead product candidate, is being developed to manage postoperative ileus, the gastrointestinal side effect, which can affect millions of patients following many types of surgery. Entereg? is also being developed to manage bowel dysfunction, which can negatively impact the quality of life for millions of patients using opioid analgesic products such as morphine for treating pain, as well as being developed for treating chronic constipation in patients not using opioids. Adolor is collaborating with GlaxoSmithKline for the development and commercialization of Entereg?. Adolor's next product candidate is a sterile lidocaine patch in clinical development for treating postoperative incisional pain. Adolor also has a number of discovery research programs focused on the identification of novel compounds for the treatment of pain. By applying its knowledge and expertise in pain management, along with ingenuity, Adolor Corporation is seeking to make a positive difference for patients, caregivers, and the medical community. For additional information, visit www.adolor.com.

About Target Software Inc.

Target Software is the fastest growing provider of state-of-the-art mobile pharmaceutical sales force automation software in the U.S. Nearly 50 pharmaceutical sales forces have been successfully deployed on the Target SFA suite. Target Software provides Target BackOffice, a complete sales information management solution at the home office and combines it with Target Mobile, the company's industry-leading mobile sales software. Target Software provides excellent functionality for both primary care and account-focused sales teams. A wide range of management reporting, sample accountability and data warehousing tools are also available. Target Software offers a full range of implementation, support and data management services to pharmaceutical clients of all sizes. For more information, visit www.targetsoftware.com

Contact Information:

John Jason
Vice President of Marketing

Target Software, Inc.
1245 S. Cedar Crest Blvd.
Allentown PA 18103

Tel: 484-223-2184
Fax: 610-820-9394
Email: John Jason

www.targetsoftware.com